Related references
Note: Only part of the references are listed.Current management and treatment strategies for breast cancer
John H. Howard et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells
J. Zaric et al.
ONCOGENE (2012)
Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3
Shuzhen Chen et al.
CANCER RESEARCH (2011)
Biology of Cox-2: An Application in Cancer Therapeutics
Zakir Khan et al.
CURRENT DRUG TARGETS (2011)
Cell cycle regulation in hematopoietic stem cells
Eric M. Pietras et al.
JOURNAL OF CELL BIOLOGY (2011)
Cucurbitacin B Suppresses the Transactivation Activity of RelA/p65
Hong Ri Jin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL)
Prashant Bavi et al.
JOURNAL OF PATHOLOGY (2011)
Molecular imaging of tumor metabolism and apoptosis
U. Haberkorn et al.
ONCOGENE (2011)
A quantitative model for cyclin-dependent kinase control of the cell cycle: revisited
Frank Uhlmann et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study
Likun Chen et al.
MEDICAL ONCOLOGY (2008)
BCL-2 family proteins: Critical checkpoints of apoptotic cell death
Nika N. Danial
CLINICAL CANCER RESEARCH (2007)
Nuclear factor-κB activation:: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
Sindhu Singh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
Sabine Groesch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patients
C. Montagut et al.
ENDOCRINE-RELATED CANCER (2006)
Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells
Gavin P. Collett et al.
CARCINOGENESIS (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells
HK Kang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
GD Basu et al.
BREAST CANCER RESEARCH (2005)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
NF-κB stimulates Akt phosphorylation and gene expression by distinct signaling mechanisms
FY Meng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2003)
Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis
HG Yu et al.
ONCOLOGY (2003)
Akt is a downstream target of NF-κB
FY Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells
A Ricca et al.
BRITISH JOURNAL OF CANCER (2001)
The nuclear factor kappa B (NF-κB):: A potential therapeutic target for estrogen receptor negative breast cancers
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
L-929 cells harboring ectopically expressed Re1A resist curcumin-induced apoptosis
RJ Anto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)